Mark Eisner - 02 Mar 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Medical Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol
FGEN
Transactions as of
02 Mar 2023
Transactions value $
-$25,960
Form type
4
Filing time
06 Mar 2023, 15:59:26 UTC
Previous filing
23 Feb 2023
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale -$26K -1.19K -0.68% $21.87* 172K 02 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.